Chemical Component Summary

Name(R)-4-((R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(tert-butoxymethyl)piperazine-2-one
Identifiers(3~{R})-4-[(3~{R})-3-azanyl-4-[2,4,5-tris(fluoranyl)phenyl]butanoyl]-3-[(2-methylpropan-2-yl)oxymethyl]piperazin-2-one
FormulaC19 H26 F3 N3 O3
Molecular Weight401.42
TypeNON-POLYMER
Isomeric SMILESCC(C)(C)OC[C@@H]1C(=O)NCCN1C(=O)C[C@@H](Cc2cc(c(cc2F)F)F)N
InChIInChI=1S/C19H26F3N3O3/c1-19(2,3)28-10-16-18(27)24-4-5-25(16)17(26)8-12(23)6-11-7-14(21)15(22)9-13(11)20/h7,9,12,16H,4-6,8,10,23H2,1-3H3,(H,24,27)/t12-,16-/m1/s1
InChIKeyLCDDAGSJHKEABN-MLGOLLRUSA-N

Chemical Details

Formal Charge0
Atom Count54
Chiral Atom Count2
Bond Count55
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB12625 
NameEvogliptin
Groupsinvestigational
DescriptionEvogliptin has been used in trials studying the treatment and screening of Osteoporosis, Renal Impairment, Type 2 Diabetes Mellitus, Diabetes Mellitis Type 2, and Diabetes Mellitus, Type 2.
SynonymsEvogliptin
Categories
  • Agents causing angioedema
  • Alimentary Tract and Metabolism
  • Blood Glucose Lowering Agents
  • Dipeptidyl Peptidase 4
  • DPP-IV Inhibitors
ATC-Code
  • A10BH07
  • A10BD22
CAS number1222102-29-5

Related Resource References

Resource NameReference
PubChem25022354
ChEMBLCHEMBL1779710
PharosCHEMBL1779710